These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 5710246)

  • 1. Results of the second chemotherapy trial of the IUAT. Bacteriological part.
    Lind A; Rist N
    Bull Int Union Tuberc; 1968 Dec; 41():178. PubMed ID: 5710246
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics.
    Zierski M
    Bull Int Union Tuberc; 1968 Dec; 41():194-200. PubMed ID: 4303863
    [No Abstract]   [Full Text] [Related]  

  • 3. [Refractory tuberculosis: concept and clinical cases].
    Sunahara S
    Naika; 1971 Jun; 27(6):1358-63. PubMed ID: 4997127
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience in treatment of patients with chronic destructive pulmonary tuberculosis in a suburban tuberculosis hospital].
    Sirota DS; Man'kovetskiĭ EF; Koĭfman SG; Vatsyk MZ
    Probl Tuberk; 1974; (10):17-9. PubMed ID: 4370967
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug therapy of resistant cases of pulmonary tuberculosis in Indian patients.
    Mital OP; Agarwala MC; Singh SK
    Indian J Chest Dis; 1967 Oct; 9(4):196-206. PubMed ID: 4323543
    [No Abstract]   [Full Text] [Related]  

  • 6. Newer and second-line drugs in the treatment of drug-resistant tuberculosis in children.
    Steiner M
    Med Clin North Am; 1967 Sep; 51(5):1153-67. PubMed ID: 4297572
    [No Abstract]   [Full Text] [Related]  

  • 7. Results after retreatment of advanced pulmonary tuberculosis with rifampin and other drugs.
    Pines A
    Am Rev Respir Dis; 1971 Jul; 104(1):126-7. PubMed ID: 4104090
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of treatment of chronic destructive pulmonary tuberculosis with reserve tuberculostatic preparations including some new preparations].
    Rabukhin AE; Alekseeva VM; Ivanova ES; Kubyshkina VF; Kliuchareva EA
    Probl Tuberk; 1970; 48(8):18-22. PubMed ID: 5496733
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of 2 or 3 secondary drug combinations in the retreatment of chronic pulmonary tuberculosis].
    De March Ayuela P; Turell Gumá J
    Rev Clin Esp; 1968 Apr; 109(2):117-26. PubMed ID: 4904020
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immediate results of treatment of tuberculosis patients with drugs of the second series].
    Ivanova ES; Komarova AA
    Sov Med; 1967 Jun; 30(6):107-10. PubMed ID: 5611339
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combination of ethambutol with ethionamide, cycloserine and-or pyrazynamide in retreatment of pulmonary tuberculosis].
    Kekkaku; 1968 Feb; 43(2):91-5. PubMed ID: 5678013
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment of urogenital tuberculosis with current drugs].
    König K; May P
    Urologe; 1968; 7(1):23-9. PubMed ID: 4297580
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
    Fegiz G
    Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
    [No Abstract]   [Full Text] [Related]  

  • 14. [Triple reserved scheme in the treatment of resistent forms of pulmonary tuberculosis (preliminary results)].
    Rizzo A; Magalhães M; Moura N
    Rev Bras Med; 1969 Sep; 26(9):504-10. PubMed ID: 5381888
    [No Abstract]   [Full Text] [Related]  

  • 15. The combination of ethambutol, capreomycin and a third drug in chronic pulmonary tuberculosis with bacterial polyresistance.
    Schütz I; Radenbach KL; Bartmann K
    Antibiot Chemother; 1970; 16():43-58. PubMed ID: 4108895
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug therapy of pulmonary tuberculosis].
    Forschbach G
    Prax Klin Pneumol; 1978 Dec; 32(12):749-68. PubMed ID: 103085
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and bacteriological experimentation with a new antitubercular chemotherapeutic agent: ethambutol].
    Serra C; Andreis G
    G Ital Chemioter; 1966; 13(1):109-27. PubMed ID: 4967318
    [No Abstract]   [Full Text] [Related]  

  • 18. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
    Mitchison DA
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethionamide, pyrazinamide and cycloserine in drug resistant cases.
    Narang RK; Singh SK
    Indian J Chest Dis; 1973 Jan; 15(1):16-20. PubMed ID: 4695462
    [No Abstract]   [Full Text] [Related]  

  • 20. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
    Ige OM; Bakare NA; Onadeko BO
    Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.